“India’s Use of Patent Opposition Mechanism as an Access to Drugs Strategy: An Empirical Analysis” (2024) Journal of Intellectual Property Rights (JIPR), 29(4), pp. 253–264. doi:10.56042/jipr.v29i4.3704.